LEXARIA BIOSCIENCE CORP. Marketable Securities, Unrealized Gain (Loss)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Marketable Securities, Unrealized Gain (Loss) of $0 for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for the quarter ending 2026-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for the quarter ending 2026-02-28 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for the quarter ending 2025-11-30 was -$22.09K.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for the quarter ending 2025-08-31 was -$11.45K, a 220.49% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for fiscal 2025 was -$33.71K.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for fiscal 2024 was -$69.83K.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for fiscal 2023 was -$221.69K.
- LEXARIA BIOSCIENCE CORP. marketable securities, unrealized gain (loss) for fiscal 2022 was -$764.61K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $0.00 10-Q · filed 2026-07-13 | $0.00 derived: sum of 2 quarters · filed 2026-07-13 | -$22.09K 10-Q · filed 2026-07-13 | -$33.54K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2026-02-28 | $0.00 10-Q · filed 2026-04-13 | -$22.09K 10-Q · filed 2026-04-13 | -$33.54K derived: sum of 3 quarters · filed 2026-04-13 | -$73.92K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2025-11-30 | -$22.09K 10-Q · filed 2026-01-13 | -$33.54K derived: sum of 2 quarters · filed 2026-01-13 | -$73.92K derived: sum of 3 quarters · filed 2026-07-13 | -$39.88K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2025-08-31 | -$11.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | -$51.82K derived: sum of 2 quarters · filed 2026-07-13 | -$17.78K derived: sum of 3 quarters · filed 2026-07-13 | -$33.71K 10-K · filed 2025-11-28 | |||
| 2025-05-31 | -$40.38K 10-Q · filed 2026-07-13 | -$6.33K derived: sum of 2 quarters · filed 2026-07-13 | -$22.27K 10-Q · filed 2026-07-13 | -$12.77K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2025-02-28 | $34.04K 10-Q · filed 2026-04-13 | $18.11K 10-Q · filed 2026-04-13 | $27.61K derived: sum of 3 quarters · filed 2026-04-13 | -$13.79K derived: sum of 4 quarters · filed 2026-04-13 | |||
| 2024-11-30 | -$15.93K 10-Q · filed 2026-01-13 | -$6.43K derived: sum of 2 quarters · filed 2026-01-13 | -$47.83K derived: sum of 3 quarters · filed 2026-01-13 | -$32.55K derived: sum of 4 quarters · filed 2026-01-13 | |||
| 2024-08-31 | $9.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | -$31.89K derived: sum of 2 quarters · filed 2025-11-28 | -$16.62K derived: sum of 3 quarters · filed 2025-11-28 | -$69.83K 10-K · filed 2025-11-28 | |||
| 2024-05-31 | -$41.39K 10-Q · filed 2025-07-14 | -$26.12K derived: sum of 2 quarters · filed 2025-07-14 | -$79.33K 10-Q · filed 2025-07-14 | -$223.25K derived: sum of 4 quarters · filed 2025-07-14 | |||
| 2024-02-29 | $15.27K 10-Q · filed 2025-04-14 | -$37.94K 10-Q · filed 2025-04-14 | $37.94K 10-Q · filed 2024-04-09 | -$181.86K derived: sum of 3 quarters · filed 2025-04-14 | -$339.27K derived: sum of 4 quarters · filed 2025-04-14 | ||
| 2023-11-30 | -$53.22K 10-Q · filed 2025-01-10 | -$197.13K derived: sum of 2 quarters · filed 2025-01-10 | -$354.54K derived: sum of 3 quarters · filed 2025-01-10 | -$197.28K derived: sum of 4 quarters · filed 2025-01-10 | |||
| 2023-08-31 | -$143.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$301.32K derived: sum of 2 quarters · filed 2024-11-26 | -$144.06K derived: sum of 3 quarters · filed 2024-11-26 | -$221.69K 10-K · filed 2024-11-26 | |||
| 2023-05-31 | -$157.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | -$147.00 derived: sum of 2 quarters · filed 2024-07-12 | -$77.78K 10-Q · filed 2024-07-12 | $77.78K 10-Q · filed 2023-07-14 | -$1.67M derived: sum of 4 quarters · filed 2024-07-12 | ||
| 2023-02-28 | $157.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $79.63K 10-Q · filed 2024-04-09 | -$79.63K 10-Q · filed 2023-04-14 | -$1.51M derived: sum of 3 quarters · filed 2024-04-09 | -$403.51K derived: sum of 4 quarters · filed 2024-04-09 | ||
| 2022-11-30 | -$77.63K 10-Q · filed 2024-01-12 | -$1.67M derived: sum of 2 quarters · filed 2024-01-12 | -$560.77K derived: sum of 3 quarters · filed 2024-01-12 | -$501.82K derived: sum of 4 quarters · filed 2024-01-12 | |||
| 2022-08-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | -$483.14K derived: sum of 2 quarters · filed 2023-11-20 | -$424.20K derived: sum of 3 quarters · filed 2023-11-20 | -$764.61K 10-K · filed 2023-11-20 | |||
| 2022-05-31 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14 | $1.16M derived: sum of 2 quarters · filed 2023-07-14 | $823.92K 10-Q · filed 2023-07-14 | -$823.92K 10-Q · filed 2022-07-14 | $744.47K derived: sum of 4 quarters · filed 2023-07-14 | ||
| 2022-02-28 | $58.94K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14 | -$281.47K 10-Q · filed 2023-04-14 | $281.47K 10-Q · filed 2022-04-11 | -$360.92K derived: sum of 3 quarters · filed 2023-04-14 | -$464.68K derived: sum of 4 quarters · filed 2023-04-14 | ||
| 2021-11-30 | -$340.42K 10-Q/A · filed 2023-01-18 | -$419.86K derived: sum of 2 quarters · filed 2023-01-18 | -$523.62K derived: sum of 3 quarters · filed 2023-01-18 | -$564.99K derived: sum of 4 quarters · filed 2023-01-18 | |||
| 2021-08-31 | -$79.44K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | -$183.21K derived: sum of 2 quarters · filed 2022-11-28 | -$224.57K derived: sum of 3 quarters · filed 2022-11-28 | -$166.25K 10-K · filed 2022-11-28 | $166.25K 10-K · filed 2021-11-29 | ||
| 2021-05-31 | -$103.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | -$145.12K derived: sum of 2 quarters · filed 2022-07-14 | -$86.81K 10-Q · filed 2022-07-14 | $86.81K 10-Q · filed 2021-07-15 | -$121.76K derived: sum of 4 quarters · filed 2022-07-14 | ||
| 2021-02-28 | -$41.36K 10-Q · filed 2021-04-14 | $16.95K 10-Q · filed 2022-04-11 | -$16.95K 10-Q · filed 2021-04-14 | -$18.00K derived: sum of 3 quarters · filed 2021-11-29 | $1.66K derived: sum of 4 quarters · filed 2021-11-29 | ||
| 2020-11-30 | $24.41K 10-Q · filed 2021-01-14 | $23.37K derived: sum of 2 quarters · filed 2021-11-29 | $43.02K derived: sum of 3 quarters · filed 2021-11-29 | $44.00K derived: sum of 4 quarters · filed 2021-11-29 | |||
| 2020-08-31 | -$1.04K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $18.61K derived: sum of 2 quarters · filed 2021-11-29 | $19.59K derived: sum of 3 quarters · filed 2021-11-29 | $19.89K 10-K · filed 2021-11-29 | -$19.89K 10-K · filed 2020-10-15 | ||
| 2020-05-31 | $19.65K 10-Q · filed 2020-06-29 | $20.64K derived: sum of 2 quarters · filed 2021-04-14 | $20.94K 10-Q · filed 2021-07-15 | -$20.94K 10-Q · filed 2020-06-29 | -$31.56K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2020-02-29 | $983.00 10-Q · filed 2021-04-14 | -$40.59K 10-Q · filed 2021-04-14 | -$51.22K derived: sum of 3 quarters · filed 2021-04-14 | -$47.50K derived: sum of 4 quarters · filed 2021-04-14 | |||
| 2019-11-30 | -$41.57K 10-Q · filed 2021-01-14 | -$52.20K derived: sum of 2 quarters · filed 2021-01-14 | -$48.49K derived: sum of 3 quarters · filed 2021-01-14 | -$48.38K derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | -$10.63K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | -$6.91K derived: sum of 2 quarters · filed 2020-10-15 | -$6.80K derived: sum of 3 quarters · filed 2020-10-15 | -$16.43K 10-K · filed 2020-10-15 | |||
| 2019-05-31 | $3.71K 10-Q · filed 2020-06-29 | $3.82K derived: sum of 2 quarters · filed 2020-06-29 | -$5.81K 10-Q · filed 2020-06-29 | ||||
| 2019-02-28 | $109.00 10-Q · filed 2020-04-03 | -$9.52K 10-Q · filed 2020-04-03 | |||||
| 2018-11-30 | -$9.63K 10-Q · filed 2020-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |